| Literature DB >> 25400948 |
Amol M Karmarkar1, James E Graham1, Timothy A Reistetter2, Amit Kumar1, Jacqueline M Mix3, Paulette Niewczyk3, Carl V Granger3, Kenneth J Ottenbacher1.
Abstract
The purpose of this study was to determine independent influences of functional level and lower limb amputation type on inpatient rehabilitation outcomes. We conducted a secondary data analysis for patients with lower limb amputation who received inpatient medical rehabilitation (N = 26,501). The study outcomes included length of stay, discharge functional status, and community discharge. Predictors included the 3-level case mix group variable and a 4-category amputation variable. Age of the sample was 64.5 years (13.4) and 64% were male. More than 75% of patients had a dysvascular-related amputation. Patients with bilateral transfemoral amputations and higher functional severity experienced longest lengths of stay (average 13.7 days) and lowest functional rating at discharge (average 79.4). Likelihood of community discharge was significantly lower for those in more functionally severe patients but did not differ between amputation categories. Functional levels and amputation type are associated with rehabilitation outcomes in inpatient rehabilitation settings. Patients with transfemoral amputations and those in case mix group 1003 (admission motor score less than 36.25) generally experience poorer outcomes than those in other case mix groups. These relationships may be associated with other demographic and/or health factors, which should be explored in future research.Entities:
Year: 2014 PMID: 25400948 PMCID: PMC4221898 DOI: 10.1155/2014/961798
Source DB: PubMed Journal: Rehabil Res Pract ISSN: 2090-2867
Demographic characteristics and rehabilitation outcomes by amputation levels.
| Total | ul TT | ul TF | bl TT | bl TF | |
|---|---|---|---|---|---|
|
| 26,501 | 15,798 | 7,495 | 1,610 | 1,598 |
| Demographics | |||||
| Age∗ | 64.5 ± 13.4 | 63.8 ± 13.2 | 66.3 ± 13.6 | 62.6 ± 13.5 | 64.2 ± 13.1 |
| Men (%)∗ | 64.0 | 65.7 | 59.9 | 68.5 | 62.5 |
| Race/ethnicity∗% | |||||
| Non-Hispanic white | 63.5 | 63 | 66.7 | 57.5 | 58.3 |
| Black | 21.0 | 20.4 | 20.2 | 25.8 | 26 |
| Hispanic | 7.6 | 8.5 | 6.2 | 7.1 | 6.7 |
| Other | 7.9 | 8.1 | 6.9 | 9.6 | 8.9 |
| Married (%)∗ | 50.4 | 50.7 | 50.1 | 52.9 | 47.6 |
| Etiology-dysvascular (%)∗ | 76.5 | 79.8 | 68.7 | 80.4 | 76.8 |
| Diabetes (%)∗ | 66.0 | 72.8 | 50.3 | 76.6 | 62.1 |
| Comorbidities (sum)∗ | 2.2 ± 1.4 | 2.3 ± 1.4 | 1.9 ± 1.3 | 2.7 ± 1.5 | 2.3 ± 1.5 |
| Case mix group∗(%) | |||||
| CMG1001 | 8.3 | 8.5 | 8.4 | 8.1 | 6.7 |
| CMG1002 | 29.3 | 31.6 | 27.1 | 24.8 | 21.7 |
| CMG1003 | 62.3 | 59.9 | 64.5 | 67.1 | 71.6 |
| Admission functional rating | |||||
| FIM motor admission∗ | 38.8 ± 11.4 | 39.6 ± 11.1 | 37.9 ± 11.8 | 37.6 ± 11.6 | 35.5 ± 11.8 |
| FIM cog admission∗ | 27.3 ± 6.4 | 27.5 ± 6.2 | 26.9 ± 6.6 | 26.9 ± 6.3 | 26.7 ± 6.7 |
| FIM total admission∗ | 67.9 ± 16.4 | 69 ± 15.9 | 66.7 ± 17 | 66.2 ± 16.5 | 63.8 ± 17 |
| Rehabilitation outcomes | |||||
| FIM motor discharge∗ | 55 ± 14.1 | 56.1 ± 13.5 | 54.2 ± 14.7 | 53.2 ± 14.1 | 50.4 ± 15.2 |
| FIM cog discharge∗ | 29.5 ± 5.7 | 29.9 ± 5.5 | 29.2 ± 6 | 29.3 ± 5.8 | 28.6 ± 6.4 |
| FIM total discharge∗ | 88 ± 19.4 | 89.5 ± 18.6 | 86.8 ± 20.2 | 85.7 ± 19.4 | 82 ± 21.2 |
| Length of stay (days)∗ | 13.3 ± 6.5 | 13.2 ± 6.4 | 13.2 ± 6.5 | 13.6 ± 6.9 | 14.2 ± 6.8 |
| Discharged home (%) | 72.4 | 72.6 | 72.4 | 71.8 | 70.7 |
ul = unilateral, bl = bilateral, TF = transfemoral, and TT = transtibial.
∗A significant relationship between amputation category and denoted variable at P < .05.
Case mix groups (CMGs) are calculated from weighted admission FIM motor ratings: CMG 1001 (FIM motor greater than 47.65), CMG 1002 (FIM motor greater than 36.25 and less than 47.65), and CMG 1003 (FIM motor less than 36.25).
Figure 1Length of stay by amputation levels for case mix group after adjustment of function. ul = unilateral, bl = bilateral, TF = transfemoral, and TT = transtibial.
Figure 2Discharge FIM rating by amputation levels for case mix group after adjustment of function. ul = unilateral, bl = bilateral, TF = transfemoral, and TT = transtibial.
Figure 3Community discharge by amputation levels for CMG after adjustment of function. ul = unilateral, bl = bilateral, TF = transfemoral, and TT = transtibial.
Coefficient estimates from multiple linear regression models: predictors for length of stay and discharge FIM rating, source UDSMR database.
| Variables | Length of stay | Discharge FIM rating | ||
|---|---|---|---|---|
| Coefficient estimate | Confidence interval (95%) | Coefficient estimate | Confidence interval (95%) | |
| Age, yrs | 0.03∗ | 0.02 to 0.032 | −0.29∗ | −0.31 to −0.27 |
| Male | 0.27∗ | 0.12 to 0.432 | −1.27∗ | −1.69 to −0.85 |
| White | −0.24∗ | −0.40 to −0.088 | 2.32∗ | 1.90 to 2.73 |
| Married | −0.78∗ | −0.93 to −0.63 | −0.22 | −0.62 to 0.18 |
| Dysvascular | 0.11 | −0.06 to 0.29 | −1.14∗ | −1.61 to −0.66 |
| Diabetes | 0.35∗ | 0.18 to 0.52 | −0.014 | −0.45 to 0.43 |
| Comorbid, sum | 0.26∗ | 0.22 to 0.29 | −0.53∗ | −0.62 to −0.45 |
| CMG 1003 (Ref) | ||||
| CMG 1002 | −3.22∗ | −3.96 to −2.5 | 18.17∗ | 16.23 to 20.11 |
| CMG 1001 | −4.16∗ | −5.37 to −2.9 | 23.02∗ | 19.79 to 26.25 |
| bl TF (Ref) | ||||
| bl TT | −0.41 | −0.91 to 0.10 | 3.08∗ | 1.74 to 4.42 |
| ul TF | −0.59∗ | −0.98 to −0.19 | 3.76∗ | 2.72 to 4.81 |
| ul TT | −0.42∗ | −0.79 to −0.04 | 6.17∗ | 5.18 to 7.16 |
| CMG 1002 × bl TT | 0.13 | −0.88 to 1.1 | −1.76 | −4.44 to .92 |
| CMG 1002 × ul TF | −0.14 | −0.93 to 0.66 | −0.45 | −2.56 to 1.66 |
| CMG 1002 × ul TT | −0.25 | −1.01 to 0.51 | −3.15∗ | −5.16 to −1.13 |
| CMG 1001 × bl TT | −0.89 | −2.53 to 0.76 | −3.65 | −8.01 to 0.70 |
| CMG 1001 × ul TF | −0.95 | −2.27 to 0.36 | −1.46 | −4.94 to 2.03 |
| CMG 1001 × ul TT | −1.92∗ | −3.18 to −0.65 | −2.97 | −6.32 to 0.38 |
ul = unilateral, bl = bilateral, TF = transfemoral, and TT = transtibial.
∗Significance at P < .05.
× = interaction term.
Odds ratios from multiple logistic regression model.
| Variables | Community discharge | |
|---|---|---|
| Odds ratio | Confidence interval (95%) | |
| Age, yrs | 0.98 | 0.98 to 0.99 |
| Male | 1.13 | 1.06 to 1.20 |
| White | 0.97 | 0.91 to 1.03 |
| Married | 1.51∗ | 1.42 to 1.60 |
| Dysvascular | 0.94 | 0.88 to 1.01 |
| Diabetes | 1.06 | 0.99 to 1.13 |
| Comorbid, sum | 0.95 | 0.93 to 0.96 |
| CMG 1003 (Ref) | ||
| CMG 1002 | 2.56∗ | 1.86 to 3.52 |
| CMG 1001 | 4.54∗ | 2.26 to 9.12 |
| bl TF (Ref) | ||
| bl TT | 0.99 | 0.82 to 1.18 |
| ul TF | 0.96 | 0.83 to 1.10 |
| ul TT | 0.93 | 0.82 to 1.06 |
| CMG 1002 × bl TT | 1.36 | 0.86 to 1.68 |
| CMG 1002 × ul TF | 1.56∗ | 1.10 to 1.33 |
| CMG 1002 × ul TT | 1.20 | 0.86 to 1.67 |
| CMG 1001 × bl TT | 0.56 | 0.23 to 1.33 |
| CMG 1001 × ul TF | 1.60 | 0.73 to 3.47 |
| CMG 1001 × ul TT | 1.43 | 0.69 to 2.97 |
ul = unilateral, bl = bilateral, TF = transfemoral, and TT = transtibial.
∗Significance at P < .05.
× = interaction term.